Previous Close | 15.50 |
Open | 15.50 |
Bid | 15.15 x 47300 |
Ask | 16.40 x 28000 |
Day's Range | 15.50 - 15.50 |
52 Week Range | 10.80 - 15.70 |
Volume | |
Avg. Volume | 1,045 |
Market Cap | 13.6B |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | 43.17 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.38 (2.48%) |
Ex-Dividend Date | Oct 03, 2024 |
1y Target Est | N/A |
New TOTAL ANKLE Patient-Matched Guides pair with Smith+Nephew’s Total Ankle replacement solution, designed to help surgeons save time and ensure accuracy while performing fewer steps than standard instrumentationFDA clearance expands 3D Systems’ leadership in supporting orthopedic surgeons, with surgical planning experience now exceeding 175,000 cases3D Systems engineers and manufactures custom, patient-specific orthopedic solutions leveraging its VSP surgical planning workflows that include mar
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its TOTAL ANKLE Patient-Matched Guides, giving surgeons a predictable and efficient option to help plan and perform total ankle replacement (TAR) procedures. Engineered using 3D Systems’ VSP® surgical planning workflows, all-in-one TOTAL ANKLE Patient-Matched Guides are designed to achieve a precise patient fit using fluoroscopic alignment cues and efficient instrumentation, and provide accuracy
VALENCIA, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, is pleased to announce that industry leader Robin VanDenburgh has joined as Senior Vice President of U.S. Commercial Sales, effective August 6, 2024. VanDenburgh, who most recently served as Vice President of Key Accounts at Smith & Nephew (NYSE: SNN), will spearhead AVI